Beta Drugs Share Price
₹2,060.05 -66.95 (-3.15%)
21 Dec, 2024 18:21
Start SIP in BETA
Start SIPPerformance
- Low
- ₹2,051
- High
- ₹2,127
- 52 Week Low
- ₹1,060
- 52 Week High
- ₹2,326
- Open Price₹2,127
- Previous Close₹2,127
- Volume2,800
Investment Returns
- Over 1 Month + 2.24%
- Over 3 Month + 21.24%
- Over 6 Month + 71.61%
- Over 1 Year + 46.4%
Smart Investing Starts Here Start SIP with Beta Drugs for Steady Growth!
Beta Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -
- PEG Ratio
- -
- Market Cap Cr
- 1,981
- P/B Ratio
- 12.6
- Average True Range
- 92.57
- EPS
- 37.9
- Dividend Yield
- 0
- MACD Signal
- 48.18
- RSI
- 44.27
- MFI
- 36.64
Beta Drugs Financials
Beta Drugs Technicals
EMA & SMA
Current Price
₹2,060.05
-66.95
(-3.15%)
- Bullish Moving Average 7
- Bearish Moving Average 9
- 20 Day
- ₹2,138.12
- 50 Day
- ₹2,028.23
- 100 Day
- ₹1,849.96
- 200 Day
- ₹1,628.44
Resistance and Support
2079.33
- R3 2,183.62
- R2 2,155.28
- R1 2,107.67
- S1 2,031.72
- S2 2,003.38
- S3 1,955.77
Beta Drugs Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-06 | Quarterly Results | |
2024-10-19 | To consider Fund Raising | |
2024-05-14 | Audited Results | |
2023-11-07 | Quarterly Results & Others | To consider the Migration of the Equity shares of the Company from Emerge-SME Platform of National Stock Exchange of India Limited ( NSE Emerge ) to the Main board of NSE and BSE. |
2023-05-08 | Audited Results |
Beta Drugs F&O
About Beta Drugs
- NSE Symbol
- BETA
- BSE Symbol
- 531481
- Chairperson & Managing Director
- Mr. Rahul Batra
- ISIN
- INE351Y01019
Similar Stocks to Beta Drugs
Beta Drugs FAQs
Beta Drugs share price is ₹2,060 As on 21 December, 2024 | 18:07
The Market Cap of Beta Drugs is ₹1980.5 Cr As on 21 December, 2024 | 18:07
The P/E ratio of Beta Drugs is As on 21 December, 2024 | 18:07
The PB ratio of Beta Drugs is 12.6 As on 21 December, 2024 | 18:07
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.